Repurposing homeopathic drug Lachesis 200C as an anticancer activity: In vitro and in ovo study

Cancer is one of the most critical health burdens with leading causes of death worldwide. Homeopathy is one of the complementary and alternative therapies, which utilizes venoms and toxins in ultra-high dilutions for therapeutics. In the present investigation, we used the homeopathy Lachesis 200C drug to study anticancer activity on the mouse fibroblast cells [L929], human prostate cancer cells [PC3], and in chick embryo model. Treating with Lachesis 200C showed 91.10% and 37.47% reduction in cell viability in L929 and PC3 respectively as compared to control by MTT assay. In the chick embryo model Lachesis 200C (dose of 50% and 100%) treatment resulted in antiangiogenic activity as compared to the control group. There was an antiproliferative and cytotoxic activity of Lachesis 200C in PC3 and L929 ​cell lines. Lachesis 200C inhibited the growth of PC3 cells. In the in vivo studies, Lachesis 200C treated chicks showed a significant decrease in or complete disappearance of blood vessels from chorioallantoic membrane (CAM) areas compared to control. The findings indicate that the level of angiogenesis was dramatically decreased by Lachesis 200C. Lachesis 200C showed the potential to act as an anticancer agent. Further studies with Lachesis200 could lead to a potential anticancer agent.